|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 1 August 2007
doi: 10.1242/dev.02879
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,*
1 KAN Research Institute Inc., KobeMI R&D Center 6-7-3
Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan.
2 Department of Neurosurgery, Kyoto University Graduate School of Medicine, 54
Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
* Author for correspondence (e-mail: y-ono{at}kan.eisai.co.jp)
Accepted 7 June 2007
Directed differentiation and purification of mesencephalic dopaminergic (mesDA) neurons from stem cells are crucial issues for realizing safe and efficient cell transplantation therapies for Parkinson's disease. Although recent studies have identified the factors that regulate mesDA neuron development, the mechanisms underlying mesDA neuron specification are not fully understood. Recently, it has been suggested that mesencephalic floor plate (FP) cells acquire neural progenitor characteristics to generate mesDA neurons. Here, we directly examined this in a fate mapping experiment using fluorescence-activated cell sorting (FACS) with an FP cell-specific surface marker, and demonstrate that mesencephalic FP cells have neurogenic activity and generate mesDA neurons in vitro. By contrast, sorted caudal FP cells have no neurogenic potential, as previously thought. Analysis of dreher mutant mice carrying a mutation in the Lmx1a locus and transgenic mice ectopically expressing Otx2 in caudal FP cells demonstrated that Otx2 determines anterior identity that confers neurogenic activity to FP cells and specifies a mesDA fate, at least in part through the induction of Lmx1a. We further show that FACS can isolate mesDA progenitors, a suitable transplantation material, from embryonic stem cell-derived neural cells. Our data provide insights into the mechanisms of specification and generation of mesDA neurons, and illustrate a useful cell replacement approach for Parkinson's disease.
Key words: Parkinson's disease, Cell replacement therapy, Dopaminergic neuron, Floor plate cells, Neurogenic activity, Lmx1a, Otx2, Embryonic stem cells, Mouse, Rat
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Tang, Y. Miyamoto, and E. J. Huang Multiple roles of {beta}-catenin in controlling the neurogenic niche for midbrain dopamine neurons Development, June 15, 2009; 136(12): 2027 - 2038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Friling, E. Andersson, L. H. Thompson, M. E. Jonsson, J. B. Hebsgaard, E. Nanou, Z. Alekseenko, U. Marklund, S. Kjellander, N. Volakakis, et al. Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells PNAS, May 5, 2009; 106(18): 7613 - 7618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cai, A. Donaldson, M. Yang, M. S. German, G. Enikolopov, and L. Iacovitti The Role of Lmx1a in the Differentiation of Human Embryonic Stem Cells into Midbrain Dopamine Neurons in Culture and After Transplantation into a Parkinson's Disease Model Stem Cells, January 1, 2009; 27(1): 220 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Omodei, D. Acampora, P. Mancuso, N. Prakash, L. G. Di Giovannantonio, W. Wurst, and A. Simeone Anterior-posterior graded response to Otx2 controls proliferation and differentiation of dopaminergic progenitors in the ventral mesencephalon Development, October 15, 2008; 135(20): 3459 - 3470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Hedlund, J. Pruszak, T. Lardaro, W. Ludwig, A. Vinuela, K.-S. Kim, and O. Isacson Embryonic Stem Cell-Derived Pitx3-Enhanced Green Fluorescent Protein Midbrain Dopamine Neurons Survive Enrichment by Fluorescence-Activated Cell Sorting and Function in an Animal Model of Parkinson's Disease Stem Cells, June 1, 2008; 26(6): 1526 - 1536. [Abstract] [Full Text] [PDF]
|
|
